Bis-(imidazole/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
858 0
SM ISO690:2012
ANTOCI, Vasilichia, CUCU, Dumitrela, ZBANCIOC, Gheorghita N., MOLDOVEANU, Costel, MANGALAGIU, Violeta, AMĂRIUCĂI-MANTU, Dorina, ARICU, Aculina, MANGALAGIU, Ionel. Bis-(imidazole/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity. In: Future Medicinal Chemistry, 2020, nr. 3(12), pp. 207-222. ISSN 1756-8919. DOI: https://doi.org/10.4155/fmc-2019-0063
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Future Medicinal Chemistry
Numărul 3(12) / 2020 / ISSN 1756-8919 /ISSNe 1756-8927

Bis-(imidazole/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity

DOI: https://doi.org/10.4155/fmc-2019-0063

Pag. 207-222

Antoci Vasilichia1, Cucu Dumitrela1, Zbancioc Gheorghita N.1, Moldoveanu Costel1, Mangalagiu Violeta21, Amăriucăi-Mantu Dorina1, Aricu Aculina3, Mangalagiu Ionel1
 
1 Alexandru Ioan Cuza University of Iaşi,
2 Institute of Interdisciplinary Research – CERNESIM Centre,
3 Institute of Chemistry
 
Proiecte:
 
Disponibil în IBN: 6 martie 2020


Rezumat

Aim: Over the last decades, few significant achievements have been made in tuberculosis (TB) therapy. As a result, there is an urgent need for new anti-TB drugs. Results: Two new classes of bis-(imidazole/benzimidazole)-pyridine derivatives were designed, synthesized and evaluated for their antimycobacterial activity. Conclusion: The synthesis is efficient and straightforward, involving only two successive N-alkylations. The anti-TB assay reveal that our compounds have an excellent anti-TB activity against both replicating and nonreplicating Mtb, are not cytotoxic, exhibited a very good intracellular activity and are active against drug-resistant Mtb strains, some compounds have a bactericidal mechanism. The absorption, distribution, metabolism, excretion and toxicity studies performed for one compound are promising, indicating that it is a good candidate for a future drug.

Cuvinte-cheie
ADMET, antimycobacterial, bis-(imidazole/benzimidazole)-pyridine, MBC, MIC

Crossref XML Export

<?xml version='1.0' encoding='utf-8'?>
<doi_batch version='4.3.7' xmlns='http://www.crossref.org/schema/4.3.7' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.crossref.org/schema/4.3.7 http://www.crossref.org/schema/deposit/crossref4.3.7.xsd'>
<head>
<doi_batch_id>ibn-97459</doi_batch_id>
<timestamp>1711696160</timestamp>
<depositor>
<depositor_name>Information Society Development Instiute, Republic of Moldova</depositor_name>
<email_address>idsi@asm.md</email_address>
</depositor>
</head>
<body>
<journal>
<journal_metadata>
<full_title>Future Medicinal Chemistry</full_title>
<issn media_type='print'>17568919</issn>
</journal_metadata>
<journal_issue>
<publication_date media_type='print'>
<year>2020</year>
</publication_date>
<issue>3(12)</issue>
</journal_issue>
<journal_article publication_type='full_text'><titles>
<title>Bis-(imidazole/benzimidazole)-pyridine derivatives: Synthesis, structure and antimycobacterial activity</title>
</titles>
<contributors>
<person_name sequence='first' contributor_role='author'>
<given_name>Vasilichia</given_name>
<surname>Antoci</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Dumitrela</given_name>
<surname>Cucu</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Gheorghita N.</given_name>
<surname>Zbancioc</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Costel</given_name>
<surname>Moldoveanu</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Violeta</given_name>
<surname>Mangalagiu</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Dorina</given_name>
<surname>Amăriucăi-Mantu</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Aculina</given_name>
<surname>Arîcu</surname>
</person_name>
<person_name sequence='additional' contributor_role='author'>
<given_name>Ionel</given_name>
<surname>Mangalagiu</surname>
</person_name>
</contributors>
<publication_date media_type='print'>
<year>2020</year>
</publication_date>
<pages>
<first_page>207</first_page>
<last_page>222</last_page>
</pages>
<doi_data>
<doi>10.4155/fmc-2019-0063</doi>
<resource>http://www.crossref.org/</resource>
</doi_data>
</journal_article>
</journal>
</body>
</doi_batch>